Clinical trial
Dendritic Cell Vaccination for the Adult Ovarian Cancer
NCT05270720 is registered in ClinicalTrials.gov with West China Second University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Dendritic Cell Vaccination for the Adult Ovarian Cancer
- Lead sponsor
- West China Second University Hospital
- Phase
- Phase 1
- Overall status
- Unknown status
- Start date
- September 1, 2022
- Completion date
- March 1, 2024
- Enrollment
- 9 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
recurrent ovarian cancer